During the past decade, University Eye Hospital conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "University Eye Hospital" are "Retinopathy of Prematurity" (1 trials) and "Retinopathy of Prematurity (ROP)" (1 trials). Many other conditions were trialed in "University Eye Hospital" in a lesser frequency.

Most popular intervention types in "University Eye Hospital" are "Biological" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Registry of preterm born infants with treatment-requiring ROP" (1 trials) and "ranibizumab" (1 trials). Other intervention names were less common.

The vast majority of trials in "University Eye Hospital" are 2 trials for "All" genders.

Currently, there are NaN active trials in "University Eye Hospital". undefined are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in University Eye Hospital, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in University Eye Hospital, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".